TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹501 Cr | ₹445 Cr | ₹393 Cr | ₹369 Cr | ₹370 Cr |
What is the latest Long Term Provisions ratio of TORRENT PHARMACEUTICALS ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹501 Cr |
| Mar2024 | ₹445 Cr |
| Mar2023 | ₹393 Cr |
| Mar2022 | ₹369 Cr |
| Mar2021 | ₹370 Cr |
How is Long Term Provisions of TORRENT PHARMACEUTICALS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹501 Cr | 12.72 | |
| Mar2024 | ₹445 Cr | 13.14 | |
| Mar2023 | ₹393 Cr | 6.60 | |
| Mar2022 | ₹369 Cr | -0.24 | |
| Mar2021 | ₹370 Cr | - | |
Compare Long Term Provisions of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹142,884.3 Cr | 3.6% | 6% | 36.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,054.0 Cr | 0.9% | 6.2% | -1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,075.0 Cr | 2% | 4.8% | 4.6% | Stock Analytics | |
| CIPLA | ₹107,358.0 Cr | -0.1% | -3% | -8.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,813.0 Cr | 1% | 10.8% | 4.7% | Stock Analytics | |
| MANKIND PHARMA | ₹84,111.1 Cr | -1.1% | -3% | -16.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 3.6% |
6% |
36.9% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses